Carna Biosciences, Inc. (TYO:4572)

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Drug Discovery Support Business	579.06M	636.24M	918.24M	1.10B	889.53M
Drug Discovery Business	-	-	707.65M	286.05M	1.13B
Total	579.06M	636.24M	1.63B	1.39B	2.02B

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Japan	169.19M	198.82M	223.31M	218.75M	205.06M
China	96.55M	92.47M	128.72M	202.92M	71.77M
United States of America	259.61M	276.86M	-	-	-
Others	5.99M	6.80M	26.33M	37.88M	17.89M
Europe	47.71M	61.29M	112.95M	72.02M	80.97M
North America	-	-	1.13B	855.19M	1.64B
Total	579.06M	636.23M	1.63B	1.39B	2.02B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error